Science Explorer Back to mapMap
Discussion
Company · Princeton · United States

Advaxis (United States)

Research works
51
▼ 59% vs 2018-21
Citations
950
18.6 per fractional work
Top-10% rate
12.6%
all institutions 10.0%
Open access
60%
world 40%
International
11%
world 18%

Not ranked overall: Advaxis (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Advaxis (United States) work in?

In all years, 39% of research at Advaxis (United States) is in Social Sciences, 36% in Life Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (25%), Arts and Humanities (24%), Medicine (12%). It does 2.0× the world's share of Life Sciences.

Social Sciences: 20 fractional works · 38.9% of its workArts and Humanities: 12 fractional works · 23.5% of its workVisual Arts and Performing Arts: 10 fractional works · 19.6% of its workPhilosophy: 1 fractional works · 2.0% of its workConservation: 1 fractional works · 1.3% of its workMusic: 0 fractional works · 0.6% of its workSocial Sciences: 5 fractional works · 10.7% of its workCultural Studies: 4 fractional works · 6.9% of its workEducation: 1 fractional works · 1.6% of its workSociology and Political Science: 1 fractional works · 1.3% of its workGender Studies: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 1 fractional works · 2.6% of its workExperimental and Cognitive Psychology: 1 fractional works · 2.6% of its workBusiness, Management and Accounting: 0 fractional works · 1.0% of its workAccounting: 0 fractional works · 1.0% of its workDecision Sciences: 0 fractional works · 1.0% of its workManagement Science and Operations Research: 0 fractional works · 1.0% of its workLife Sciences: 18 fractional works · 36.2% of its workBiochemistry, Genetics and Molecular Biology: 13 fractional works · 24.7% of its workBiotechnology: 9 fractional works · 18.3% of its workMolecular Biology: 2 fractional works · 3.0% of its workGenetics: 1 fractional works · 2.7% of its workEndocrinology: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.3% of its workImmunology and Microbiology: 5 fractional works · 10.5% of its workImmunology: 5 fractional works · 10.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workFood Science: 0 fractional works · 0.6% of its workInsect Science: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.2% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.2% of its workPhysical Sciences: 7 fractional works · 13.0% of its workEngineering: 5 fractional works · 10.5% of its workBiomedical Engineering: 3 fractional works · 6.5% of its workCivil and Structural Engineering: 1 fractional works · 2.2% of its workControl and Systems Engineering: 0 fractional works · 0.8% of its workElectrical and Electronic Engineering: 0 fractional works · 0.6% of its workMechanical Engineering: 0 fractional works · 0.3% of its workMaterials Science: 1 fractional works · 1.3% of its workCeramics and Composites: 0 fractional works · 0.6% of its workMaterials Chemistry: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 1 fractional works · 1.1% of its workEcology: 1 fractional works · 1.1% of its workChemistry: 0 fractional works · 0.1% of its workHealth Sciences: 6 fractional works · 12.0% of its workMedicine: 6 fractional works · 12.0% of its workEpidemiology: 3 fractional works · 5.5% of its workSurgery: 1 fractional works · 1.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.3% of its workOncology: 1 fractional works · 1.1% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.4% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workImmunology and Allergy: 0 fractional works · 0.2% of its workObstetrics and Gynecology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workALL ITS WORKAdvaxis (UnitedStates)51fractional works, all years
Life Sciences36%Physical Sciences13%Health Sciences12%Social Sciences39%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Arts and Humanities1223.5%
    2. Social Sciences510.7%
    3. Psychology12.6%
    4. Business, Management and Accounting01.0%
    5. Decision Sciences01.0%
    1. Biochemistry, Genetics and Molecular Biology1324.7%
    2. Immunology and Microbiology510.5%
    3. Agricultural and Biological Sciences00.8%
    4. Neuroscience00.2%
    1. Engineering510.5%
    2. Materials Science11.3%
    3. Environmental Science11.1%
    4. Chemistry00.1%
    1. Medicine612.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.62× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 2.77× its world share, 0 worksImmunology and Micro…Engineering: 0.12× its world share, 0 worksEngineeringMedicine: 0.45× its world share, 0 worksMedicineArts and Humanities: 22.40× its world share, 4 worksArts and HumanitiesPsychology: 1.77× its world share, 0 worksPsychologySocial Sciences: 1.07× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Arts and Humanities, 22.4×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Arts and Humanities22.40×4 works
  2. Immunology and Microbiology2.77×0 works
  3. Psychology1.77×0 works
  4. Social Sciences1.07×1 works
  5. Biochemistry, Genetics and Molecular Biology0.62×0 works
  6. Medicine0.45×0 works
  7. Engineering0.12×0 works

Who are the top researchers at Advaxis (United States)?

Ranked on the quality score, Robert G. Petit, Anu Wallecha and Andres A. Gutierrez lead among researchers whose main affiliation is Advaxis (United States).

  1. 1 Robert G. Petit United States · #822,098 worldwide 1.5k citations · 44 works
  2. 2 Anu Wallecha United States · #2,085,709 worldwide 1.3k citations · 71 works
  3. 3 Andres A. Gutierrez United States · #2,333,148 worldwide 1.2k citations · 54 works
  4. 4 John Rothman United States · #2,699,809 worldwide 716 citations · 23 works
  5. 5 Sandy Hayes United States · #4,456,115 worldwide 115 citations · 38 works
All ranked researchers at Advaxis (United States)

What are the most cited papers from Advaxis (United States)?

The most cited paper from Advaxis (United States) is "The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix" (Paulo Maciag, Sinisa S. Radulovic, John Rothman, 2009), with 327 citations. Next come "Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer" (289) and "A Randomized Phase 2 Study of ADXS11-001 Listeria monocy'togenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer" (184).

Most cited papers
#PaperReleasedCitations
1 The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix Paulo Maciag, Sinisa S. Radulovic, John Rothman · Vaccine 4 May 2009 327
2 Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer Davide Melisi, Rocio García‐Carbonero, Teresa Mercade Macarulla et al. · British Journal of Cancer Open access 10 Oct 2018 289
3 A Randomized Phase 2 Study of ADXS11-001 Listeria monocy'togenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer Partha Sarathi Basu, Ajay Omprakash Mehta, Minish Mahendra Jain et al. · International Journal of Gynecological Cancer Open access 14 Mar 2018 184
4 Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer Daniel O. Villarreal, Andrew L'Huillier, Susan Armington et al. · Cancer Research 19 Jul 2018 143
5 Development of a Listeria monocytogenes based vaccine against prostate cancer Vafa Shahabi, Mariela Reyes-Reyes, Anu Wallecha et al. · Cancer Immunology Immunotherapy Open access 13 Feb 2008 95
All 44 most cited papers, with filters and sorting

Which keywords describe research at Advaxis (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Performativity, Tumor Targeting, Gene Therapy, Arginine Deprivation, Bacterial Therapy, Globalization and Performance Art.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy9▲ 28×7 topics
  2. Performativity9▲ 698×2 topics
  3. Tumor Targeting9▲ 135×2 topics
  4. Gene Therapy8▲ 61×3 topics
  5. Globalization6▲ 6.9×3 topics
  6. Arginine Deprivation6▲ 286×1 topic
  7. Bacterial Therapy6▲ 286×1 topic
  8. Performance Art6▲ 689×1 topic
  9. Theatre6▲ 382×1 topic
  10. Qualitative Research6▲ 19×2 topics
  11. Immunity5▲ 27×2 topics
  12. Innate Immunity5▲ 27×2 topics
  13. Antigen Presentation4▲ 87×2 topics
  14. Cancer Immunotherapy4▲ 61×1 topic
  15. Dendritic Cells4▲ 75×1 topic
  16. Feminism4▲ 29×3 topics
  17. Education4▲ 5.5×4 topics
  18. Nanoparticles4▲ 5.4×3 topics
  19. Affect4▲ 242×1 topic
  20. Epidemiology4▲ 1.69×10 topics
  21. Posthumanism4▲ 712×1 topic
  22. Photothermal Therapy3▲ 63×1 topic
  23. Reactive Oxygen Species3▲ 11×1 topic
  24. Foodborne Illness3▲ 110×2 topics
  25. Global Burden3▲ 9.6×3 topics
  26. Pathogenicity3▲ 57×2 topics
  27. Cervical Cancer2▲ 48×2 topics
  28. Food Safety2▲ 18×2 topics
  29. Human Papillomavirus2▲ 37×2 topics
  30. Cancer Incidence2▲ 32×1 topic
  31. HPV Vaccination2▲ 88×1 topic
  32. Listeria monocytogenes2▲ 237×1 topic
  33. fresh produce2▲ 237×1 topic
  34. Neuroscience2▲ 13×3 topics
  35. Creative Drama2▲ 1579×1 topic
  36. Social Skills2▲ 67×1 topic
  37. Genomics2▲ 9.7×3 topics
  38. Social Justice2▲ 6.5×3 topics
  39. AAV1▲ 42×1 topic
  40. Viral Vectors1▲ 42×1 topic

Which research topics does Advaxis (United States) publish most on?

By volume in 2022-now: Theatre and Performance Studies, Creative Drama in Education, Artistic and Creative Research and Posthumanist Ethics and Activism.

  1. 1 Theatre and Performance Studies Visual Arts and Performing Arts 2 works
  2. 2 Creative Drama in Education Visual Arts and Performing Arts 1 works
  3. 3 Artistic and Creative Research Visual Arts and Performing Arts 1 works
  4. 4 Posthumanist Ethics and Activism Cultural Studies 1 works
  5. 5 Art Education and Development Visual Arts and Performing Arts 0 works
  6. 6 Cultural Studies and Interdisciplinary Research Philosophy 0 works
  7. 7 Diversity and Impact of Dance Experimental and Cognitive Psychology 0 works
  8. 8 Congenital Anomalies and Fetal Surgery Surgery 0 works
  9. 9 Neuroendocrine Tumor Research Advances Epidemiology 0 works
  10. 10 Diverse Education Studies and Reforms Education 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.3%not open39.7%

World: 40% of research is openly available.

with international co-authors11.4%domestic only88.6%

World: 18% is written across borders.

How has Advaxis (United States)'s research output changed?

Output in 2022-2025 was 59% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Advaxis (United States) as a percentage of every work published that year, 0.000037% in 2023.

still counting0.00010%0.00020%Advaxis (United States)0.000027% in 202520102020

Fractional works of Advaxis (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Princeton

All research institutions in Princeton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Advaxis (United States). Posts are plain text and can be reported.